Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia-Reference-Cited by-同舟云学术

Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia

Published:2017-08-20 Issue:10 Volume:21 Page:933-947
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Ruiz-Llorente Lidia¹,Gallardo-Vara Eunate¹,Rossi Elisa²,Smadja David M.²,Botella Luisa M.¹,Bernabeu Carmelo¹

Affiliation:

1. Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain

2. Faculté de Pharmacie, Paris Descartes University, Sorbonne Paris Cité and Inserm UMR-S1140, Paris, France

Funder

Ministerio de Industria, Economia y Competitividad of Spain

Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) of Spain

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2017.1365839

Reference125 articles.

1. Ultrastructure and Three-Dimensional Organization of the Telangiectases of Hereditary Hemorrhagic Telangiectasia

2. Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment

3. Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesis

4. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)

5. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy;Journal of Biomedical Science;2024-06-27

2. Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT);Cell & Bioscience;2024-05-22

3. Hereditary hemorrhagic telangiectasia with hepatic arteriovenous shunt diagnosed due to liver damage;Clinical Journal of Gastroenterology;2024-03-04

4. The ENG/VEGFα Pathway Is Likely Affected by a Nonsense Variant of Endoglin (ENG)/CD105, Causing Hereditary Hemorrhagic Telangiectasia Type 1 (HHT1) in a Chinese Family;Genes;2024-02-27

5. Endoglin mutants retained in the endoplasmic reticulum exacerbate loss of function in hereditary hemorrhagic telangiectasia type 1 (HHT1) by exerting dominant negative effects on the wild type allele;Traffic;2024-01